Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (121-130 of 518) with videos related to

Pageof 52
Sort By:
Psychiatry Research|December 2, 2008
The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorderRobert Arbuckle, Mark A Frye, Martin Brecher, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trialsMark A Frye, James Eudicone, Andrei Pikalov, et al.
Bipolar Disorders|September 3, 2021
First manic episode following COVID-19 infectionJin Hong Park, Megan Kummerlowe, Manuel Gardea Resendez, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept studyJoseph R Calabrese, Terence A Ketter, James M Youakim, et al.
Psychiatry Research. Neuroimaging|January 1, 2022
Racemic ketamine treatment attenuates anterior cingulate cortex GABA deficits among remitters in treatment-resistant depression: A pilot studyBalwinder Singh, John D Port, Vanessa Pazdernik, et al.
Journal of Clinical Psychopharmacology|September 28, 2022
The Modernization of Clozapine: A Recapitulation of the Past in the United States and the View ForwardJonathan G Leung, Jose de Leon, Mark A Frye, et al.
Bipolar Disorders|April 19, 2012
Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorderGin S Malhi, Danielle M Bargh, Roger McIntyre, et al.
Frontiers in Psychiatry|January 30, 2026
Leveraging reddit data for context-enhanced synthetic health data generation to identify low self esteemMuskan Garg, Xingyi Liu, Eunji Jeon, et al.
Journal of Affective Disorders|September 8, 2015
Screening for bipolar disorders: Clinical utilization of the Mood Disorders Questionnaire on an inpatient mood disorders unitSimon Kung, Brian A Palmer, Maria I Lapid, et al.
Psychopharmacology Bulletin|October 5, 2020
Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-AnalysisMehak Pahwa, Nicolas A Nuñez, Boney Joseph, et al.
Pageof 52

Showing results (121-130 of 518) with videos related to

Sort By:
Pageof 52
Psychiatry Research|December 2, 2008
The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorderRobert Arbuckle, Mark A Frye, Martin Brecher, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trialsMark A Frye, James Eudicone, Andrei Pikalov, et al.
Bipolar Disorders|September 3, 2021
First manic episode following COVID-19 infectionJin Hong Park, Megan Kummerlowe, Manuel Gardea Resendez, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept studyJoseph R Calabrese, Terence A Ketter, James M Youakim, et al.
Psychiatry Research. Neuroimaging|January 1, 2022
Racemic ketamine treatment attenuates anterior cingulate cortex GABA deficits among remitters in treatment-resistant depression: A pilot studyBalwinder Singh, John D Port, Vanessa Pazdernik, et al.
Journal of Clinical Psychopharmacology|September 28, 2022
The Modernization of Clozapine: A Recapitulation of the Past in the United States and the View ForwardJonathan G Leung, Jose de Leon, Mark A Frye, et al.
Bipolar Disorders|April 19, 2012
Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorderGin S Malhi, Danielle M Bargh, Roger McIntyre, et al.
Frontiers in Psychiatry|January 30, 2026
Leveraging reddit data for context-enhanced synthetic health data generation to identify low self esteemMuskan Garg, Xingyi Liu, Eunji Jeon, et al.
Journal of Affective Disorders|September 8, 2015
Screening for bipolar disorders: Clinical utilization of the Mood Disorders Questionnaire on an inpatient mood disorders unitSimon Kung, Brian A Palmer, Maria I Lapid, et al.
Psychopharmacology Bulletin|October 5, 2020
Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-AnalysisMehak Pahwa, Nicolas A Nuñez, Boney Joseph, et al.
Pageof 52